メニューにジャンプコンテンツにジャンプ

トップページ > 診療科・部門 > センター > がん総合診療センター > 研究実績・活動実績 > 2021年度発表論文等一覧

2021年度発表論文等一覧

原著論文-英文

  1. Oishi T, Sasaki Y, Tong Y, Chen L, Onodera T, Iwasa S, Udo E, Furusato B, Fujimori H, Imamichi S, Honda T, Bessho T, Fukuoka J, Ashizawa K, Yanagihara K, Nakao K, Yamada Y, Hiraoka N, Masutani M.
    A newly established monoclonal antibody against ERCC1 detects major isoforms of ERCC1 in gastric cancer.
    Glob Health Med 3:226-235, 2021.
  2. Iwasa S, Muro K, Morita S, Park YS, Nakamura M, Kotaka M, Nishina T, Matsuoka H, Ahn JB, Lee KW, Hong YS, Han SW, Cho SH, Zhang DS, Fang WJ, Bai L, Yuan XL, Yuan Y, Yamada Y, Sakamoto J, Kim TW.
    Impact of UGT1A1 genotype on the efficacy and safety of irinotecan-based chemotherapy in metastatic colorectal cancer.
    Cancer Sci, 2021 epub (IF:6.716)
  3. Denda T, Takashima A, Gamoh M, Iwanaga I, Komatsu Y, Takahashi M, Nakamura M, Ohori H, Sakashita A, Tsuda M, Kobayashi Y, Baba H, Kotake M, Ishioka C, Yamada Y, Sato A, Yuki S, Morita S, Takahashi S, Yamaguchi T, Shimada K.
    Combination therapy of bevacizumab with either S-1 and irinotecan or mFOLFOX6/CapeOX as first-line treatment of metastatic colorectal cancer (TRICOLORE): Exploratory analysis of RAS status and primary tumour location in a randomised, open-label, phase III, non-inferiority trial.
    Eur J Cancer 154:296-306, 2021. (IF:9.162)
  4. Fukahori M, Kato K, Taniguchi H, Ohtomo R, Takahashi N, Shoji H, Iwasa S, Honma Y, Takashima A, Hamaguchi T, Yamada Y, Shimada Y, Ito Y, Itami J, Hokamura N, Igaki H, Tachimori Y, Miwa K, Torimura T, Boku N.
    Relationship between cervical esophageal squamous cell carcinoma and human papilloma virus infection and gene mutations.
    Mol Clin Oncol 14:41, 2021. (IF:1.5)
  5. Suzuki K, Naito T, Tanaka H, Shibata K, Yamada Y, Itoh K, Kawakami J.
    Impact of CYP2D6 activity and cachexia progression on enantiomeric alteration of plasma tramadol and its demethylated metabolites and their relationships with central nervous system symptoms in head and neck cancer patients.
    Basic Clin Pharmacol Toxicol 128:472-481, 2021. (IF: 2.651)